Organization
Innolake Biopharm
3 clinical trials
Clinical trial
A Phase Ia, Multicenter, Open-label Study of ILB2109 in Patients With Advanced Solid MalignanciesStatus: Recruiting, Estimated PCD: 2023-11-01
Clinical trial
A Phase Ib/IIa, Multicenter, Open-label Study of ILB2109 and Toripalimab in Patients With Advanced Solid MalignanciesStatus: Not yet recruiting, Estimated PCD: 2026-01-25
Clinical trial
Phase I/II Study of the ILB-3101 in Patients With Advanced Solid TumorsStatus: Not yet recruiting, Estimated PCD: 2025-12-01